ANTIPODES PARTNERS Ltd Purchases 6,124,238 Shares of Brookdale Senior Living Inc. (NYSE:BKD)

ANTIPODES PARTNERS Ltd grew its holdings in Brookdale Senior Living Inc. (NYSE:BKD - Free Report) by 81.0% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 13,684,500 shares of the company's stock after acquiring an additional 6,124,238 shares during the quarter. Brookdale Senior Living accounts for 2.7% of ANTIPODES PARTNERS Ltd's portfolio, making the stock its 17th largest holding. ANTIPODES PARTNERS Ltd owned approximately 6.84% of Brookdale Senior Living worth $85,672,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. GAMMA Investing LLC lifted its position in shares of Brookdale Senior Living by 1,999.4% in the 1st quarter. GAMMA Investing LLC now owns 7,180 shares of the company's stock worth $45,000 after acquiring an additional 6,838 shares during the period. Lazard Asset Management LLC lifted its position in shares of Brookdale Senior Living by 6,029.2% in the 4th quarter. Lazard Asset Management LLC now owns 9,868 shares of the company's stock worth $49,000 after acquiring an additional 9,707 shares during the period. Crestline Management LP bought a new stake in shares of Brookdale Senior Living in the 4th quarter worth approximately $64,000. Freestone Grove Partners LP bought a new stake in shares of Brookdale Senior Living in the 4th quarter worth approximately $65,000. Finally, Sherbrooke Park Advisers LLC bought a new stake in shares of Brookdale Senior Living in the 4th quarter worth approximately $80,000.

Analyst Ratings Changes

BKD has been the subject of a number of recent research reports. Barclays increased their target price on Brookdale Senior Living from $7.00 to $7.50 and gave the stock an "equal weight" rating in a report on Wednesday, April 16th. Royal Bank Of Canada reissued an "outperform" rating and issued a $9.00 target price on shares of Brookdale Senior Living in a report on Wednesday, July 9th. Finally, Wall Street Zen cut Brookdale Senior Living from a "hold" rating to a "sell" rating in a report on Sunday, July 20th. Two research analysts have rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $7.70.

Brookdale Senior Living Price Performance

BKD stock traded up $0.07 during midday trading on Friday, reaching $7.51. 2,165,280 shares of the company's stock traded hands, compared to its average volume of 3,128,507. The company has a 50-day simple moving average of $6.99 and a two-hundred day simple moving average of $6.15. Brookdale Senior Living Inc. has a 1-year low of $4.45 and a 1-year high of $8.08. The company has a market cap of $1.76 billion, a price-to-earnings ratio of -7.22 and a beta of 0.83. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 28.85.

Brookdale Senior Living (NYSE:BKD - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported ($0.11) EPS for the quarter, meeting analysts' consensus estimates of ($0.11). Brookdale Senior Living had a negative return on equity of 79.84% and a negative net margin of 7.52%. On average, analysts anticipate that Brookdale Senior Living Inc. will post -0.56 earnings per share for the current year.

Brookdale Senior Living Profile

Brookdale Senior Living Inc owns, manages, and operates senior living communities in the United States. It operates in three segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRCs). The Independent Living segment owns or leases communities comprising independent and assisted living units in a single community that are primarily designed for middle to upper income seniors.